Cargando…
A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
The advance of CRISPR/Cas9 technology has enabled us easily to generate gene knockout cell lines by introducing insertion–deletion mutations (indels) at the target site via the error-prone non-homologous end joining repair system. Frameshift-promoting indels can disrupt gene functions by generation...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038147/ https://www.ncbi.nlm.nih.gov/pubmed/36762651 http://dx.doi.org/10.1242/jcs.260000 |
_version_ | 1784912022516793344 |
---|---|
author | Komori, Takuma Hata, Shoji Mabuchi, Akira Genova, Mariya Harada, Tomoki Fukuyama, Masamitsu Chinen, Takumi Kitagawa, Daiju |
author_facet | Komori, Takuma Hata, Shoji Mabuchi, Akira Genova, Mariya Harada, Tomoki Fukuyama, Masamitsu Chinen, Takumi Kitagawa, Daiju |
author_sort | Komori, Takuma |
collection | PubMed |
description | The advance of CRISPR/Cas9 technology has enabled us easily to generate gene knockout cell lines by introducing insertion–deletion mutations (indels) at the target site via the error-prone non-homologous end joining repair system. Frameshift-promoting indels can disrupt gene functions by generation of a premature stop codon. However, there is growing evidence that targeted genes are not always knocked out by the indel-based gene disruption. Here, we established a pipeline of CRISPR-del, which induces a large chromosomal deletion by cutting two different target sites, to perform ‘complete’ gene knockout efficiently in human diploid cells. Quantitative analyses show that the frequency of gene deletion with this approach is much higher than that of conventional CRISPR-del methods. The lengths of the deleted genomic regions demonstrated in this study are longer than those of 95% of the human protein-coding genes. Furthermore, the pipeline enabled the generation of a model cell line having a bi-allelic cancer-associated chromosomal deletion. Overall, these data lead us to propose that the CRISPR-del pipeline is an efficient and practical approach for producing ‘complete’ gene knockout cell lines in human diploid cells. |
format | Online Article Text |
id | pubmed-10038147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-100381472023-03-25 A CRISPR-del-based pipeline for complete gene knockout in human diploid cells Komori, Takuma Hata, Shoji Mabuchi, Akira Genova, Mariya Harada, Tomoki Fukuyama, Masamitsu Chinen, Takumi Kitagawa, Daiju J Cell Sci Tools and Resources The advance of CRISPR/Cas9 technology has enabled us easily to generate gene knockout cell lines by introducing insertion–deletion mutations (indels) at the target site via the error-prone non-homologous end joining repair system. Frameshift-promoting indels can disrupt gene functions by generation of a premature stop codon. However, there is growing evidence that targeted genes are not always knocked out by the indel-based gene disruption. Here, we established a pipeline of CRISPR-del, which induces a large chromosomal deletion by cutting two different target sites, to perform ‘complete’ gene knockout efficiently in human diploid cells. Quantitative analyses show that the frequency of gene deletion with this approach is much higher than that of conventional CRISPR-del methods. The lengths of the deleted genomic regions demonstrated in this study are longer than those of 95% of the human protein-coding genes. Furthermore, the pipeline enabled the generation of a model cell line having a bi-allelic cancer-associated chromosomal deletion. Overall, these data lead us to propose that the CRISPR-del pipeline is an efficient and practical approach for producing ‘complete’ gene knockout cell lines in human diploid cells. The Company of Biologists Ltd 2023-03-07 /pmc/articles/PMC10038147/ /pubmed/36762651 http://dx.doi.org/10.1242/jcs.260000 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Tools and Resources Komori, Takuma Hata, Shoji Mabuchi, Akira Genova, Mariya Harada, Tomoki Fukuyama, Masamitsu Chinen, Takumi Kitagawa, Daiju A CRISPR-del-based pipeline for complete gene knockout in human diploid cells |
title | A CRISPR-del-based pipeline for complete gene knockout in human diploid cells |
title_full | A CRISPR-del-based pipeline for complete gene knockout in human diploid cells |
title_fullStr | A CRISPR-del-based pipeline for complete gene knockout in human diploid cells |
title_full_unstemmed | A CRISPR-del-based pipeline for complete gene knockout in human diploid cells |
title_short | A CRISPR-del-based pipeline for complete gene knockout in human diploid cells |
title_sort | crispr-del-based pipeline for complete gene knockout in human diploid cells |
topic | Tools and Resources |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038147/ https://www.ncbi.nlm.nih.gov/pubmed/36762651 http://dx.doi.org/10.1242/jcs.260000 |
work_keys_str_mv | AT komoritakuma acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT hatashoji acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT mabuchiakira acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT genovamariya acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT haradatomoki acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT fukuyamamasamitsu acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT chinentakumi acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT kitagawadaiju acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT komoritakuma crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT hatashoji crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT mabuchiakira crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT genovamariya crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT haradatomoki crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT fukuyamamasamitsu crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT chinentakumi crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells AT kitagawadaiju crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells |